Cardiac evaluation for simultaneous pancreas-kidney transplantation and incidence of cardiac perioperative complications: Preliminary study

Transplantation Proceedings

Volumn 36, Issue 3, 2004, Pages 582-585

  Fossati, N ^a   Meacci, L ^a   Amorese, G ^a   Bellissima, G ^a   Pieri, M ^a   Nardi, S ^a   Vangone, M Esposito ^a   Rondinini, L ^b   Mariotti, R ^b   Petronio, A S ^b   Boggi, U ^b   Rizzo, G ^a   Marchetti, P ^c   Sansevero, A ^a   Mosca, F ^b  

^a UNIVERSITY HOSPITAL OF PISA   (Italy)

^b Trapiani Delle Nuove Tecnologie Med   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; ANGIOCARDIOGRAPHY; CARDIOPULMONARY HEMODYNAMICS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; CORONARY ARTERY DISEASE; ECG ABNORMALITY; FEMALE; FOLLOW UP; GRAFT FAILURE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY TRANSPLANTATION; MALE; MEDICAL ASSESSMENT; PANCREAS TRANSPLANTATION; PATIENT MONITORING; PATIENT SELECTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SAMPLE SIZE; SILENT MYOCARDIAL INFARCTION; SURGICAL MORTALITY; SURVIVAL RATE; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; COMORBIDITY; CORONARY DISEASE; ECHOCARDIOGRAPHY; FEMALE; HEART DISEASES; HEART FUNCTION TESTS; HUMANS; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MALE; MIDDLE AGED; NITRATES; PANCREAS TRANSPLANTATION; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 11144355523     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2004.02.036     Document Type: Conference Paper

References (12)

1. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA. 241:1979;2035
2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the diagnosis and classification of Diabetes Mellitus. Diabetes Care. 20:1997;1183
3. Moss S.E., Klein R., Klein B.E.K., et al. The association of glycemia and cause-specific mortality in a diabetic population. Arch Intern Med. 154:1994;2473
4. Stratta R.J., Taylor R.J., Gill I.S. Pancreas transplantation a managed cure approach to diabetes. Current Problems in Surgery. 33:1996;713
5. Messerli F.H., Devereux R.B. Left ventricular hypertrophy - good or evil? Am J Med. 75:1983;1
6. Kannel W.B. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J. 13:(Suppl D):1992;82
7. Bikkina M., Larson M.G., Levy D. Asymptomatic ventricular arrhythmias and mortality risk in subjects with left ventricular hypertrophy. J Am Coll Cardiol. 22:1993;1111
8. Schweitzer E.J., Anderson L., Kuo P.C. Safe pancreas transplantation in patients with coronary artery disease. Transplantation. 63:1997;1294
9. Nicolino A., Longobardi G., Furgi G. Left ventricular diastolic filling in diabetes mellitus with and without hypertension. Am J Hypertens. 8:1995;382
10. Illan F., Valdes-Chiavarri M., Tebar J. Anatomical and functional cardiac abnormalities in type 1 diabetes. Clin Investig. 70:1992;403
11. Kannel W.B., Dannenberg A.L., Levy D. Population implications of ECG left ventricular hypertrophy. Am J Cardiol. 60:1987;851
12. Levy D., Anderson K.M., Savage D.D., et al. Echocardiographically detected left ventricular hypertrophy, prevalence and risk factors. The Framingham Heart Study. Ann Intern Med. 108:1988;2